ALSO NOTED: Eisai withdraws European Aricept application; FDA approves GSK's Altabax; and much more...
Free newsletter via e-mail
Tools
> Japan's Eisai has withdrawn its European application for Aricept as a treatment for Alzheimer's after regulators asked for more data. Report
> Novelos Therapeutics is planning a $15 million private placement. Release
> The FDA has approved GlaxoSmithKline's antibacterial Altabax. Report
> India's Lupin Pharmaceuticals has received FDA approval for a new formulation of its anti-infective Suprax. Release
> Alkermes announced that the FDA has approved a new dose of risperidone for schizophrenia. Report
And Finally... Indian officials are on alert after an outbreaK of bird flu in Bangladesh. Report
SHARE
WITH: